Chase Cavayero, DO
Urology · Fort Myers, FLNPI 1326570466
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,832 of the $4,579 with a category attached, or 61.9%. Boston Scientific accounts for 61.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $2,376 and has fallen 69.1% since, to $734 in 2025.
Across 46 payments — averaging $99.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Teleflex LLC$581
- Procept Biorobotics Corporation$382
- Intuitive Surgical$323
- Coloplast$145
- Medtronic$130
- plus $221 from 6 others
What the payments were for
- Travel & lodging$1,74738%
- Food & beverage$2,83262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 19 | $2,797 |
| Teleflex LLC | 9 | $581 |
| Procept Biorobotics Corporation | 5 | $382 |
| Intuitive Surgical | 3 | $323 |
| Coloplast | 1 | $145 |
| Medtronic(2 entities) | 3 | $130 |
| AbbVie | 1 | $127 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
| Urogen Pharma, Inc. | 1 | $16 |
| Laborie Medical Technologies Corp. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700 CXR RTE KIT$1,479
- AMS$313
- UroLift$302
- AquaBeam Robotic System$266
- TACTRA$230
- Da Vinci Surgical System$152
- Barrigel$150
- RESTORELLE$145
- BOTOX$127
- AMS 700$125
How this compares
$4,579 in reported general payments places this provider in the 55th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 12 | $171,692 |
| XtandiEnzalutamide | 13 | $169,700 |
| MyrbetriqMirabegron | 37 | $34,497 |
| Testosterone | 30 | $7,338 |
| Tamsulosin Hcl | 391 | $4,576 |
| Finasteride | 291 | $2,722 |
| Potassium Citrate ErPotassium Citrate | 25 | $2,008 |
| Estradiol | 25 | $1,725 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 63 | $1,653 |
| Bicalutamide | 47 | $1,604 |
| Solifenacin Succinate | 53 | $1,399 |
| Tolterodine Tartrate ErTolterodine Tartrate | 21 | $1,359 |
| Trospium Chloride | 24 | $1,199 |
| Methenamine Hippurate | 12 | $987 |
| Testosterone Cypionate | 31 | $969 |
Paid to pharmacies, not to this prescriber.
Other urology in Fort Myers
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Mark Anthony GonzalgoMiami$1M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
- Olubayo TojuolaOrlando$283K
- Juan SuarezCoral Gables$276K
- Michael McDonaldCelebration$272K
- Raymond PakJacksonville$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.